- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00248235
Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer
November 4, 2024 updated by: University of Alberta
Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors
The purpose of this study is to investigate the effect of a progressive therapeutic exercise program on specific physical and functional deficits in the neck and shoulder region occurring as a result of head and neck cancer treatment.
Study Overview
Detailed Description
We will be conducting a randomized controlled trial to evaluate the effects of progressive resistance exercise training (PRET) on shoulder and neck dysfunction due to spinal accessory neurapraxia/ neurectomy in patients with head and neck cancer.
Sixty-four head and neck cancer survivors will be randomly assigned to PRET or standard care.
Participants assigned to the PRET group will exercise 3 times per week for 12 weeks.
The goal of the exercise program will be to enhance scapular stability, and improve mobility and strength of the upper extremity.
The resistance exercise program will be progressive in terms of the number of sets and repetitions performed, as well as amount lifted, depending on baseline strength levels and overall performance status.
The primary outcomes for the study include pain and dysfunction, active and passive range of motion measures, strength and endurance testing, and quality of life.
Nerve conduction testing and electromyography will be performed to assess/ monitor the status of the spinal accessory nerve and trapezius muscle function respectively.
Study Type
Interventional
Enrollment (Actual)
64
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2H9
- Behavioral Medicine Laboratory, University of Alberta
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx OR squamous cell carcinoma metastatic to the neck from unknown primary site; probable occult mucosal origin in the head and neck
- Surgical treatment includes radical neck dissection, modified radical neck dissection and other variants of functional/selective neck dissection
- Karnofsky Performance Status greater than or equal to 60%
- No evidence of residual cancer in the neck and no distant (M0) metastasis
- Participants must have completed their head and neck cancer treatment
Exclusion Criteria:
- A history of shoulder or neck pathology unrelated to cancer treatment
- Serious co-morbid medical illness or psychiatric illness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PRET
Progressive Resistance Exercise Training: upper extremity 6-8 exercises
|
|
|
Active Comparator: Standard Care
Standard Care: physical therapy - range of motion, 6-8 strengthening exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain and dysfunction (baseline, 12 weeks, 6 months, 12 months)
Time Frame: baseline, 12 weeks, 6 months, 12 months
|
baseline, 12 weeks, 6 months, 12 months
|
|
Active and passive range of motion (baseline, 12 weeks)
Time Frame: baseline, 12 weeks
|
baseline, 12 weeks
|
|
Muscular strength and endurance (baseline, 12 weeks)
Time Frame: baseline, 12 weeks
|
baseline, 12 weeks
|
|
Quality of life (baseline, 12 weeks, 6 months, 12 months)
Time Frame: baseline, 12 weeks, 6 months, 12 months
|
baseline, 12 weeks, 6 months, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Anxiety, depression and fatigue (baseline, 12 weeks, 6 months, 12 months)
Time Frame: baseline, 12 weeks, 6 months, 12 months
|
baseline, 12 weeks, 6 months, 12 months
|
|
Nerve conduction testing (baseline, 12 weeks as indicated)
Time Frame: Baseline
|
Baseline
|
|
Electromyography (baseline, 12 weeks as indicated)
Time Frame: Baseline
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kerry S Courneya, PhD, Professor, Faculty of Physical Education and Recreation, University of Alberta
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2005
Primary Completion (Actual)
May 1, 2008
Study Completion (Actual)
January 1, 2009
Study Registration Dates
First Submitted
November 1, 2005
First Submitted That Met QC Criteria
November 1, 2005
First Posted (Estimated)
November 3, 2005
Study Record Updates
Last Update Posted (Actual)
November 5, 2024
Last Update Submitted That Met QC Criteria
November 4, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HN-4-0023
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.